Blogs

More Members of Congress Sign-On to Home Infusion Legislation Following NHIA’s Hill Day, eight more members of Congress have signed on as legislative sponsors of the Preserving Patient Access to Home Infusion Act. To date, Rep. Blake Moore (R-UT), Rep. Madeleine Dean (D-PA), Rep. Burgess Owens (R-UT), Rep. Danny Davis (D-IL), Rep. Doris Matsui (D-CA), Rep. Greg Stanton (D-AZ), Rep. Darren Soto (D-IL), and Rep. Ted Lieu (D-CA) have joined the bipartisan, geographically diverse coalition supporting Medicare home infusion coverage. Thanks to these champions and to the NHIA members who reach out to their representatives for support. Learn more . | Write a ...

Introducing the NHIA Community AI Assistant Faster answers from sources you can trust If you’ve ever thought, “I know someone in the NHIA Community has already answered this,” our new AI Assistant will feel like magic. It’s designed to help you find the right information quickly —and always show where that information came from. How it works The assistant is community-powered . Most of the information it has access to is not accessible to public AI models. It retrieves and summarizes information from: NHIA Community discussions ...

NHIA Expresses Concern Over Blues Home Infusion Policy NHIA sent a letter to each of the HCSC Blues plans expressing serious concern over a change in policy (Home Infusion Policy CPCP019) that would limit per diem billing to days when a nurse is physically present in the home. The association cautioned that such a change is equivalent to eliminating coverage for home infusion for most therapies. “If you move forward with this change, you should expect that few patients will continue to access home infusion, particularly for IV anti-infectives, parenteral and enteral services, pain therapies, and other daily administered treatments,” said the letter, which ...

FDA Approves New Anti-Infective Combination for cIAI The FDA approved aztreonam and avibactam (EMBLAVEO™, Abbvie) as the first and only fixed-dose, intravenous, monobactam/β-lactamase inhibitor combination antibiotic. It is approved in combination with metronidazole, for patients 18 years and older who have limited or no alternative options for the treatment of complicated intra-abdominal infections (cIAI), including those caused by the following susceptible Gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae complex, Citrobacter freundii complex, and Serratia marcescens. Read the announcement ...

CMS Working With DOGE CMS announced that it has assigned 2 industry veterans to lead its collaboration with the Department of Government Efficiency (DOGE), including ensuring appropriate access to CMS systems and technology. “We are taking a thoughtful approach to see where there may be opportunities for more effective and efficient use of resources in line with meeting the goals of President Trump,” said the agency. Read the announcement . Tell Us What You Think About INFUSION Magazine NHIA is looking for feedback and reader impressions of INFUSION magazine. Please take a short survey and share your opinions on this member service. ...

You can use the NHIA Community to participate in online forums across the full NHIA membership or within topic-specific communities. You can also search for and direct message other members, stay up to date on upcoming events and opportunities for participation in research or advocacy, and access NHIA member resources. Check out the brief video below on how to get started by updating your profile, joining communities and participating in discussions. Connect directly with other NHIA members by using the directory or visiting their profile and adding them as a contact. You'll be able to send them a direct message by clicking on the dots beneath their title. ...